ESTRO 2024 - Abstract Book

S1287

Clinical - Head & neck

ESTRO 2024

Conclusion:

There is no significant difference in survival and locoregional control. It may be surmised that locoregional recurrences occur earlier with oropharyngeal tumours than with hypopharyngeal tumours. Majority (76%) of the oropharyngeal tumours tested negative for HPV and hence the impact of HPV positivity on treatment outcomes of these tumours cannot be commented upon and is unlikely to be relevant.

Keywords: Posterior pharyngeal wall cancer, Survival

References:

Fein DA, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):751-7. doi: 10.1016/0360-3016(93)90488-h. PMID: 8344842. De Felice F, Blanchard P, Levy A, Nguyen F, Gorphe P, Janot F, Temam S, Tao Y. Treatment of squamous cell carcinoma of the posterior pharyngeal wall: Radiotherapy versus surgery. Head Neck. 2016 Apr;38 Suppl 1:E1722-9. doi: 10.1002/hed.24307. Epub 2015 Nov 28. PMID: 26613802.

Lallemant B, Moriniere S, Ceruse P, Lebalch M, Aubry K, Hans S, Dolivet G, Malard O, Bonduelle Q, Vergez S. Transoral robotic surgery for squamous cell carcinomas of the posterior pharyngeal wall. Eur Arch